Human Monocytes Engage an Alternative Inflammasome Pathway

Immunity

Volumn 44, Issue 4, 2016, Pages 833-846

  Gaidt, Moritz M ^a   Ebert, Thomas S ^a   Chauhan, Dhruv ^a   Schmidt, Tobias ^a   Schmid Burgk, Jonathan L ^a   Rapino, Francesca ^b   Robertson, Avril A B ^c   Cooper, Matthew A ^c   Graf, Thomas ^b   Hornung, Veit ^a,d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CRYOPYRIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; CARRIER PROTEIN; IL1B PROTEIN, HUMAN; NLRP3 PROTEIN, HUMAN; POTASSIUM; POTASSIUM CHANNEL; TLR4 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROPTOSIS; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; ANIMAL; CELL LINE; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS);

ANIMALS; CARRIER PROTEINS; CASPASE 1; CELL LINE; CELL TRANSDIFFERENTIATION; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MONOCYTES; POTASSIUM; POTASSIUM CHANNELS; PYROPTOSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84962219519     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.01.012     Document Type: Article

References (53)

1. Baker P.J., Boucher D., Bierschenk D., Tebartz C., Whitney P.G., D'Silva D.B., Tanzer M.C., Monteleone M., Robertson A.A.B., Cooper M.A., et al. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur. J. Immunol. 2015, 45:2918-2926.
2. Cai X., Chen J., Xu H., Liu S., Jiang Q.X., Halfmann R., Chen Z.J. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014, 156:1207-1222.
3. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
4. Chen K.W., Groß C.J., Sotomayor F.V., Stacey K.J., Tschopp J., Sweet M.J., Schroder K. The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge. Cell Rep. 2014, 8:570-582.
5. Coll R.C., Robertson A.A., Chae J.J., Higgins S.C., Muñoz-Planillo R., Inserra M.C., Vetter I., Dungan L.S., Monks B.G., Stutz A., et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 2015, 21:248-255.
6. Danis V.A., Kulesz A.J., Nelson D.S., Brooks P.M. Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha. Clin. Exp. Immunol. 1990, 80:435-443.
7. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
8. Dinarello C.A. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur. J. Immunol. 2011, 41:1203-1217.
9. Dupont N., Jiang S., Pilli M., Ornatowski W., Bhattacharya D., Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 2011, 30:4701-4711.
10. Fernandes-Alnemri T., Wu J., Yu J.-W., Datta P., Miller B., Jankowski W., Rosenberg S., Zhang J., Alnemri E.S. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 2007, 14:1590-1604.
11. Guo H., Callaway J.B., Ting J.P.-Y. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 2015, 21:677-687.
12. Gurung P., Anand P.K., Malireddi R.K.S., Vande Walle L., Van Opdenbosch N., Dillon C.P., Weinlich R., Green D.R., Lamkanfi M., Kanneganti T.-D. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 2014, 192:1835-1846.
13. Haneklaus M., O'Neill L.A.J. NLRP3 at the interface of metabolism and inflammation. Immunol. Rev. 2015, 265:53-62.
14. Hazuda D.J., Lee J.C., Young P.R. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 α and interleukin 1 β. J. Biol. Chem. 1988, 263:8473-8479.
15. He Y., Franchi L., Núñez G. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J. Immunol. 2013, 190:334-339.
16. Hogquist K.A., Nett M.A., Unanue E.R., Chaplin D.D. Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 1991, 88:8485-8489.
17. Kang T.B., Yang S.H., Toth B., Kovalenko A., Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 2013, 38:27-40.
18. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
19. Khare S., Dorfleutner A., Bryan N.B., Yun C., Radian A.D., de Almeida L., Rojanasakul Y., Stehlik C. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 2012, 36:464-476.
20. Lamkanfi M., Dixit V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157:1013-1022.
21. Latz E., Xiao T.S., Stutz A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 2013, 13:397-411.
22. Liu T., Yamaguchi Y., Shirasaki Y., Shikada K., Yamagishi M., Hoshino K., Kaisho T., Takemoto K., Suzuki T., Kuranaga E., et al. Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response. Cell Rep. 2014, 8:974-982.
23. Lonnemann G., Endres S., Van der Meer J.W.M., Cannon J.G., Koch K.M., Dinarello C.A. Differences in the synthesis and kinetics of release of interleukin 1 α, interleukin 1 β and tumor necrosis factor from human mononuclear cells. Eur. J. Immunol. 1989, 19:1531-1536.
24. Lu A., Magupalli V.G., Ruan J., Yin Q., Atianand M.K., Vos M.R., Schröder G.F., Fitzgerald K.A., Wu H., Egelman E.H. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014, 156:1193-1206.
25. Maelfait J., Vercammen E., Janssens S., Schotte P., Haegman M., Magez S., Beyaert R. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J. Exp. Med. 2008, 205:1967-1973.
26. *). Annu. Rev. Immunol. 2009, 27:621-668.
27. McGettrick A.F., O'Neill L.A. NLRP3 and IL-1β in macrophages as critical regulators of metabolic diseases. Diabetes Obes. Metab. 2013, 15(Suppl 3):19-25.
28. Miao E.A., Leaf I.A., Treuting P.M., Mao D.P., Dors M., Sarkar A., Warren S.E., Wewers M.D., Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 2010, 11:1136-1142.
29. Moriwaki K., Bertin J., Gough P.J., Chan F.K.-M. A RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing. J. Immunol. 2015, 194:1938-1944.
30. Munford R.S. Murine responses to endotoxin: another dirty little secret?. J. Infect. Dis. 2010, 201:175-177.
31. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013, 38:1142-1153.
32. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A.B., Opitz B., van der Meer J.H.M., van de Veerdonk F.L., Ferwerda G., Heinhuis B., Devesa I., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
33. Oberst A., Green D.R. It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat. Rev. Mol. Cell Biol. 2011, 12:757-763.
34. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., Hakem R., Salvesen G.S., Green D.R. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
35. Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007, 14:1583-1589.
36. Piccini A., Carta S., Tassi S., Lasiglié D., Fossati G., Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 2008, 105:8067-8072.
37. Rapino F., Robles E.F., Richter-Larrea J.A., Kallin E.M., Martinez-Climent J.A., Graf T. C/EBPα induces highly efficient macrophage transdifferentiation of B lymphoma and leukemia cell lines and impairs their tumorigenicity. Cell Rep. 2013, 3:1153-1163.
38. Rühl S., Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur. J. Immunol. 2015, 45:2927-2936.
39. Schmid-Burgk J.L., Schmidt T., Gaidt M.M., Pelka K., Latz E., Ebert T.S., Hornung V. OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines. Genome Res. 2014, 24:1719-1723.
40. Schmid-Burgk J.L., Gaidt M.M., Schmidt T., Ebert T.S., Bartok E., Hornung V. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur. J. Immunol. 2015, 45:2911-2917.
41. Schumann R.R., Belka C., Reuter D., Lamping N., Kirschning C.J., Weber J.R., Pfeil D. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 1998, 91:577-584.
42. Sha W., Mitoma H., Hanabuchi S., Bao M., Weng L., Sugimoto N., Liu Y., Zhang Z., Zhong J., Sun B., Liu Y.J. Human NLRP3 inflammasome senses multiple types of bacterial RNAs. Proc. Natl. Acad. Sci. USA 2014, 111:16059-16064.
43. Shi J., Zhao Y., Wang Y., Gao W., Ding J., Li P., Hu L., Shao F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014, 514:187-192.
44. Storek K.M., Monack D.M. Bacterial recognition pathways that lead to inflammasome activation. Immunol. Rev. 2015, 265:112-129.
45. Thorgersen E.B., Pharo A., Haverson K., Axelsen A.K., Gaustad P., Kotwal G.J., Sfyroera G., Mollnes T.E. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood. Infect. Immun. 2009, 77:725-732.
46. Vanden Berghe T., Linkermann A., Jouan-Lanhouet S., Walczak H., Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 2014, 15:135-147.
47. Vince J.E., Wong W.W.L., Gentle I., Lawlor K.E., Allam R., O'Reilly L., Mason K., Gross O., Ma S., Guarda G., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012, 36:215-227.
48. von Moltke J., Trinidad N.J., Moayeri M., Kintzer A.F., Wang S.B., van Rooijen N., Brown C.R., Krantz B.A., Leppla S.H., Gronert K., Vance R.E. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 2012, 490:107-111.
49. Wang H., Mao L., Meng G. The NLRP3 inflammasome activation in human or mouse cells, sensitivity causes puzzle. Protein Cell 2013, 4:565-568.
50. Wang X., Jiang W., Yan Y., Gong T., Han J., Tian Z., Zhou R. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 2014, 15:1126-1133.
51. Wen H., Miao E.A., Ting J.P.Y. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013, 39:432-441.
52. Yabal M., Müller N., Adler H., Knies N., Groß C.J., Damgaard R.B., Kanegane H., Ringelhan M., Kaufmann T., Heikenwälder M., et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 2014, 7:1796-1808.
53. Zhang M., Sam K., Ge L., Xu K., Schekman R. Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. eLife 2015, Published online November 2, 2015. 10.7554/eLife.11205.